November 12, 2009 – Catheter-directed therapy or catheter-directed thrombolysis to dissolve dangerous blood clots ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
The incidence of cardiac arrhythmia is expected to increase significantly with an aging U.S. population and rising ...
November 10, 2009 – The latest data from seven studies focused on the treatment of peripheral arterial disease ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 10, 2009 – Onset Medical Corp. today said it received U.S. FDA 510(k) marketing clearance for its ...
November 10, 2009 – Clinically, stent fracture has been reported in 1-2 percent of patients after drug-eluting ...
November 9, 2009 — Two products from Prescient Medical, the vProtect Luminal Shield and the vPredict Optical ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 6, 2009 — Stereotaxis received notice this week that its Celsius RMT ThermoCool catheter received CE mark ...
November 6, 2009 – Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the ...
November 6, 2009 – Cardiac support device maker Abiomed Inc. yesterday announced second quarter fiscal 2010 ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 4, 2009 – Cordis and FDA notified healthcare professionals this week of a nationwide recall of all lots ...
November 3, 2009 – Vascular Solutions Inc. recently launched the Guardian II Hemostasis Valve. Unlike ...
November 3, 2009 – Boston Scientific Corp. yesterday said it received CE Mark for its PROMUS Element Everolimus ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
November 3, 2009 – Abbott yesterday said both the XIENCE PRIME Everolimus-Eluting Coronary Stent System and the ...
November 3, 2009 – The FDA said Boston Scientific recently changed the name of the company's Liberté Bare-Metal ...
November 2, 2009 — Increasing the flexibility and diagnostic capabilities in bi-plane vascular X-ray imaging ...
November 12, 2009